Searchable abstracts of presentations at key conferences in endocrinology

ea0081p133 | Endocrine-Related Cancer | ECE2022

Rapidly progressive cases of ectopic adrenocorticotropic hormone syndrome

Gonzalez Gracia Lucia , Lopez Gallardo Gema , Oulad Ahmed Bothayna , Dios Fuentes Elena , Beltran Romero Luis , Soto-Moreno Alfonso

Introduction: Adrenocorticotropic hormone (ACTH)-dependent Cushing’s syndrome (CS) secondary to an ectopic source is an uncommon condition, accounting for 4-5% of all cases of CS and between 9-18% of cases of ACTH-dependent CS. Although numerous malignancies have been associated with ectopic ACTH syndrome (EAS), lung neuroendocrine tumours (NETs) are the most common. Refractory hypokalemia can be the presenting feature in EAS and is seen in up to 80% of cases. We present ...

ea0090ep794 | Pituitary and Neuroendocrinology | ECE2023

MAFLD prevalence in a cohort of patients with Cushing’s disease

Remon Pablo , Gutierrez Ana Pinar , Moreno Eva Venegas , Dios-Fuentes Elena , Gonzales David Cano , Romero-Gomez Manuel , Soto-Moreno Alfonso

Objectives: To describe the prevalence of liver steatosis in a cohort of patients with Cushing’s disease.Methods: Cross-sectional descriptive study. We included 59 patients with Cushing’s disease from our cohort of patients who underwent a Fibroscan to analyze the degree of hepatic steatosis (CAP measured in dB/m) and liver fibrosis (fibrosis measured in kPa). Biochemical algorithms of liver steatosis and fibrosis were assessed.<p class="ab...

ea0081ep291 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Description of patients with diabetic foot of neuropathic and vascular cause cared for in a multidisciplinary Diabetic Foot Unit

Pinar Gutierrez Ana , Gros-Herguido Noelia , Losada-Vinau Fernando , Farfan-Diaz Fatima , Enriquez-Perez Monica , Ruiz-Trillo Carmen , Ciuro Felipe Pareja , Fuentes Lucas Mengibar , Soto-Moreno Alfonso

Objective: 6% of people with diabetes present with diabetic foot as a complication, which means greater morbidity and mortality compared to those who do not. Its diagnosis and management by multidisciplinary teams including surgeons can improve these patients’ care. The objective was to analyze the main characteristics of patients and health results obtained, as well as to evaluate the impact of PAD (peripheral artery disease) existence in patients cared for in our multid...

ea0090ep675 | Pituitary and Neuroendocrinology | ECE2023

Metabolic and surgical outcomes of adult patients with craniopharyngiomapatients undergoing extended transsphenoidal surgery (ETS) at a referral center

Pinar Gutierrez Ana , Dios Elena , Venegas-Moreno Eva , Remon Pablo , Oulad Ahmed Bothayna , Kaen Ariel , Cardenas Eugenio , Fajardo Elena , Cano Gonzales David , Soto-Moreno Alfonso

Objectives: To describe the metabolic and surgical outcomes of adult patients with craniopharyngioma undergoing extended transsphenoidal surgery (ETS). Secondary: to compare surgical outcomes with patients undergoing conventional transcranial surgery (CTS).Methods: Retrospective observational study. Adult patients with craniopharyngiomas undergoing ETS between 2015 and 2020 were included. Descriptive analysis was performed by obtaining median and quartil...

ea0063p1087 | Pituitary and Neuroendocrinology 3 | ECE2019

Surgical outcomes in cushing disease: Endoscopic transsphenoidal pituitary surgery

Remon-Ruiz Pablo , Dios-Fuentes Elena , Venegas Eva , Cozar-Duenas Miriam , Kaen Ariel , Cardenas Eugenio , Gonzalez Natividad , Martin Ignacio , Roldan Florinda , Fajardo Elena , Cano David , Soto-Moreno Alfonso

Introduction: Endoscopic transsphenoidal pituitary surgery has become the first line method for removal pituitary tumours. A new way to see the surgical field and the cooperation of two neurosurgeons has supposed a revolution in the area.Objetives: Analyse surgical outcomes and complications of a cohort of patients from a single center who underwent ETPS for Cushing disease.Methods: Descriptive prospective-retrospective study inclu...

ea0063p1091 | Pituitary and Neuroendocrinology 3 | ECE2019

Surgical outcomes in acromegaly disease: endoscopic transsphenoidal pituitary surgery

Cozar Miriam , Remon-Ruiz Pablo , Dios-Fuentes Elena , Cozar Miriam , Kaen Ariel , Cardenas Eugenio , Gonzalez Natividad , Martin Ignacio , Roldan Florinda , Fajardo Elena , Cano David , Soto-Moreno Alfonso

Introduction: Endoscopic transsphenoidal pituitary surgery has become the first line method for removal pituitary tumours. A new way to see the surgical field and the cooperation of two neurosurgeons has supposed a revolution in the area.Objetives: Analyse surgical outcomes and complications of a cohort of patients from a single center who underwent ETPS for GH secreting pituitary tumours.Methods: Descriptive prospective-retrospect...

ea0041ep855 | Pituitary - Basic | ECE2016

Biguanides: A new potential therapeutic option for pituitary tumors?

Vazquez-Borrego Ma Carmen , Ibanez-Costa Alejandro , Venegas-Moreno Eva , Galvez Ma Angeles , Soto-Moreno Alfonso , Castano Justo P. , Luque Raul M.

Pituitary adenomas (PA) comprise a commonly underestimated pathology in terms of incidence and associated morbimortality. Somatostatin and dopamine analogs constitute the main medical treatment for PA. However, an appreciable subset of patients are resistant or poorly responsive to these drugs, and hence, the search for new therapies to control tumor growth and/or hormone secretion is crucial. Biguanides such as metformin (MF; commonly used to treat type-2 diabetes), phenformi...

ea0070aep350 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

PHIGNA-DM2 study: Fatty liver and nonalcoholic steatohepatitis prevalence in type 2 diabetes in an andalusian cohort

Jesús Martínez Ortega Antonio , Remon Pablo , Deniz Garcia Alejandro , Ampuero Javier , Romero-Gomez Manuel , Pablo Garcia-Luna Pedro , Soto-Moreno Alfonso

Introduction: Non-alcoholic fatty liver disease (NAFLD) is an underdiagnosed complication in Type 2 Diabetes (T2D). This condition can evolve into steatohepatitis (NASH) and more severe entities such as liver cirrhosis and hepatic failure, being currently the first cause for liver transplantation in our environment. In Andalusian T2D patients, the exact prevalence is still unknown. Our aim is to assess the prevalence of NAFLD/NASH in a cohort of these patients.<p class="ab...

ea0070aep658 | Pituitary and Neuroendocrinology | ECE2020

Prevalence of non-alcoholic fatty liver disease in patients with Cushing disease (CD)

Remon Pablo , Venegas-Moreno Eva , Deniz-Garcia Alejandro , Millan Raquel , Dios-Fuentes Elena , Martin Natalia , Rico Maria C , Madrazo Ainara , Romero-Gómez Manuel , Soto-Moreno Alfonso

Introduction: The prevalence and comorbidities of NAFLD in CD are unknown. There is only one study wich set the prevalence of NAFLD by CT images in 20%1.Objectives: Describe the prevalence of NAFLD and fibrosis in CD and analize predictive biomarkers of NAFLDMethods: Transversal descriptive study. 31 patients with CD; 11 active, 20 cured. Women 24 (77%), men 7 (23%). 54 years mean age. NAFLD was valorated by Hepatic Stea...

ea0070ep301 | Pituitary and Neuroendocrinology | ECE2020

Can you predict the success of surgery in cushing’s disease?

Moreno-Moreno Paloma , Soto-Moreno Alfonso , Fajardo-Montañana Carmen , Camara-Gómez Rosa , Luque Raul M , Ángeles Gálvez-Moreno María

Objective: Cushing’s disease (CD) is difficult to diagnose because of its rarity and because its most common symptoms can overlap with those of other more common conditions. Remission rates in the postoperative vary between 55–85%. Overall, the mean time to diagnosis was 38 months. The objective of this study was to describe whether there is any pre-surgical clinical data that predicts CD remission after TSS.Patients and Methods: Retrospectiv...